14 Nov 2025 | 3 Mins Read
Concord Biotech reports 34% Q2 profit drop
Flipitmoney
Concord Biotech Ltd reported a 33.6% year-on-year decline in its net profit to ₹63.6 crore in Q2FY26. Revenue declined 20.4% to ₹247.1 crore. EBITDA fell 35.3% to ₹88.4 crore. The company approved a ₹10 crore solar power project and a ₹100% equity acquisition in Celliimune Biotech Pvt Ltd for strategic expansion.